Cervical cancer
Impact of HPV Vaccination on Prevention of Cervical HPV Infection in Sikkim, India
Who can joinWomen
Age18–22 years
Kind of studyObservational: no new treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
1 hospital in India taking patients for this trial.
Sikkim Manipal HospitalGangtok, SikkimDirections ↗
Registry summary (technical)
This project aims is to monitor the effectiveness of HPV vaccination in real-word conditions, at least 7 years after initiation of HPV vaccination in Sikkim. This study would give an opportunity to provide rapid feedback to the Indian public health authorities about the impact of the HPV vaccine.
Sponsor: International Agency for Research on Cancer
NCT04588402 on ClinicalTrials.gov
Last updated on the registry 3 Apr 2026 · read by us 20 Oct 2026